| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Corpus Luteum | 21 | 2010 | 91 | 3.380 |
Why?
|
| Ovarian Neoplasms | 27 | 2022 | 4712 | 2.290 |
Why?
|
| Neoplastic Stem Cells | 12 | 2018 | 1392 | 2.220 |
Why?
|
| Endometrial Neoplasms | 17 | 2017 | 1333 | 1.990 |
Why?
|
| Cyclins | 12 | 2019 | 595 | 1.560 |
Why?
|
| Uterine Neoplasms | 11 | 2018 | 1473 | 1.280 |
Why?
|
| Leiomyoma | 6 | 2018 | 685 | 1.100 |
Why?
|
| Carcinoma, Endometrioid | 4 | 2017 | 287 | 1.030 |
Why?
|
| Dinoprost | 11 | 2010 | 147 | 0.940 |
Why?
|
| Oogenesis | 3 | 2014 | 137 | 0.930 |
Why?
|
| Luteolysis | 4 | 2008 | 12 | 0.910 |
Why?
|
| Phosphoproteins | 13 | 2015 | 2550 | 0.890 |
Why?
|
| Proto-Oncogene Proteins c-kit | 4 | 2018 | 796 | 0.700 |
Why?
|
| Signal Transduction | 30 | 2019 | 23950 | 0.670 |
Why?
|
| Ovary | 7 | 2019 | 997 | 0.670 |
Why?
|
| Progesterone | 12 | 2008 | 734 | 0.660 |
Why?
|
| Carrier Proteins | 12 | 2015 | 5141 | 0.650 |
Why?
|
| Apoptosis | 18 | 2020 | 10085 | 0.640 |
Why?
|
| Oocytes | 6 | 2012 | 1217 | 0.630 |
Why?
|
| TOR Serine-Threonine Kinases | 6 | 2017 | 2118 | 0.620 |
Why?
|
| Antigens, Tumor-Associated, Carbohydrate | 1 | 2017 | 128 | 0.620 |
Why?
|
| Cell Proliferation | 20 | 2020 | 10803 | 0.590 |
Why?
|
| Xenograft Model Antitumor Assays | 12 | 2021 | 3714 | 0.580 |
Why?
|
| Endometriosis | 4 | 2014 | 773 | 0.580 |
Why?
|
| Carcinosarcoma | 2 | 2014 | 121 | 0.570 |
Why?
|
| Loss of Heterozygosity | 3 | 2007 | 681 | 0.560 |
Why?
|
| Caspases | 4 | 2003 | 940 | 0.550 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 2 | 2014 | 191 | 0.550 |
Why?
|
| Vitrification | 1 | 2014 | 41 | 0.540 |
Why?
|
| Leptin | 6 | 2009 | 1572 | 0.530 |
Why?
|
| Endometrium | 8 | 2017 | 405 | 0.520 |
Why?
|
| Receptor, erbB-2 | 6 | 2020 | 2307 | 0.510 |
Why?
|
| Carboplatin | 3 | 2014 | 797 | 0.510 |
Why?
|
| Mucin-1 | 1 | 2018 | 524 | 0.500 |
Why?
|
| Dendritic Cells | 4 | 2014 | 2726 | 0.500 |
Why?
|
| Cystadenocarcinoma, Serous | 6 | 2020 | 457 | 0.500 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2017 | 726 | 0.490 |
Why?
|
| Ovarian Follicle | 3 | 2019 | 240 | 0.490 |
Why?
|
| CA-125 Antigen | 4 | 2021 | 279 | 0.480 |
Why?
|
| Cryopreservation | 2 | 2014 | 618 | 0.470 |
Why?
|
| Gene Expression Regulation, Neoplastic | 15 | 2020 | 8638 | 0.460 |
Why?
|
| Mice | 53 | 2022 | 80876 | 0.450 |
Why?
|
| Glycoproteins | 6 | 2013 | 2309 | 0.450 |
Why?
|
| Animals | 86 | 2022 | 170486 | 0.450 |
Why?
|
| Toll-Like Receptors | 2 | 2013 | 594 | 0.440 |
Why?
|
| Teratoma | 1 | 2014 | 385 | 0.440 |
Why?
|
| Cell Line, Tumor | 25 | 2021 | 16959 | 0.430 |
Why?
|
| Female | 118 | 2022 | 375205 | 0.430 |
Why?
|
| Keratin-18 | 1 | 2010 | 40 | 0.420 |
Why?
|
| Morpholines | 2 | 2014 | 572 | 0.420 |
Why?
|
| Oligopeptides | 1 | 2017 | 1276 | 0.410 |
Why?
|
| Receptors, Progesterone | 6 | 2016 | 1108 | 0.410 |
Why?
|
| Mice, SCID | 12 | 2020 | 2835 | 0.400 |
Why?
|
| Paclitaxel | 4 | 2015 | 1655 | 0.400 |
Why?
|
| Disease Models, Animal | 10 | 2019 | 18375 | 0.400 |
Why?
|
| Sphingomyelin Phosphodiesterase | 2 | 2008 | 93 | 0.390 |
Why?
|
| Aminopyridines | 1 | 2014 | 531 | 0.390 |
Why?
|
| Uterine Cervical Neoplasms | 4 | 2022 | 1962 | 0.390 |
Why?
|
| Membrane Proteins | 5 | 2021 | 8072 | 0.380 |
Why?
|
| Receptors, Notch | 1 | 2014 | 759 | 0.380 |
Why?
|
| Peptides | 7 | 2022 | 4424 | 0.370 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2015 | 1194 | 0.360 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2014 | 920 | 0.360 |
Why?
|
| Cell Transformation, Neoplastic | 7 | 2022 | 3006 | 0.360 |
Why?
|
| DNA Repair | 1 | 2018 | 2028 | 0.350 |
Why?
|
| Tumor Necrosis Factor-alpha | 7 | 2013 | 4466 | 0.350 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2014 | 2593 | 0.340 |
Why?
|
| Antigens, CD | 5 | 2013 | 4169 | 0.340 |
Why?
|
| Gene Amplification | 6 | 2020 | 1087 | 0.340 |
Why?
|
| Granulosa Cells | 5 | 2019 | 124 | 0.340 |
Why?
|
| Genes, erbB-1 | 1 | 2008 | 168 | 0.330 |
Why?
|
| Ovarian Diseases | 1 | 2008 | 137 | 0.320 |
Why?
|
| Immunohistochemistry | 14 | 2017 | 11790 | 0.320 |
Why?
|
| Hedgehog Proteins | 1 | 2011 | 774 | 0.310 |
Why?
|
| Epithelial Cells | 3 | 2019 | 3690 | 0.310 |
Why?
|
| Growth Inhibitors | 1 | 2007 | 381 | 0.300 |
Why?
|
| Cattle | 14 | 2010 | 4006 | 0.290 |
Why?
|
| Mice, Inbred NOD | 9 | 2016 | 1918 | 0.290 |
Why?
|
| Cell Cycle | 5 | 2016 | 3014 | 0.290 |
Why?
|
| Vulvar Neoplasms | 1 | 2008 | 277 | 0.290 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2006 | 131 | 0.280 |
Why?
|
| Epigenomics | 1 | 2010 | 802 | 0.280 |
Why?
|
| RNA, Messenger | 12 | 2014 | 13314 | 0.270 |
Why?
|
| Indoles | 4 | 2016 | 1857 | 0.270 |
Why?
|
| Drug Delivery Systems | 1 | 2017 | 2277 | 0.270 |
Why?
|
| Cytokines | 6 | 2014 | 7189 | 0.270 |
Why?
|
| Neoplasm, Residual | 1 | 2010 | 996 | 0.270 |
Why?
|
| Paraffin Embedding | 2 | 2017 | 317 | 0.270 |
Why?
|
| Neoplasm Transplantation | 6 | 2013 | 2165 | 0.270 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2008 | 559 | 0.260 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 5 | 2016 | 11253 | 0.250 |
Why?
|
| Gene Silencing | 2 | 2007 | 1626 | 0.250 |
Why?
|
| Adenocarcinoma, Clear Cell | 2 | 2005 | 234 | 0.250 |
Why?
|
| Antineoplastic Agents | 9 | 2017 | 13714 | 0.250 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2007 | 676 | 0.250 |
Why?
|
| I-kappa B Proteins | 2 | 2001 | 239 | 0.250 |
Why?
|
| Humans | 90 | 2022 | 708843 | 0.250 |
Why?
|
| Carcinoma | 2 | 2015 | 2307 | 0.240 |
Why?
|
| Repressor Proteins | 3 | 2022 | 3075 | 0.240 |
Why?
|
| Pre-Eclampsia | 1 | 2012 | 1108 | 0.240 |
Why?
|
| Microsatellite Repeats | 2 | 2006 | 807 | 0.230 |
Why?
|
| MicroRNAs | 5 | 2018 | 3655 | 0.230 |
Why?
|
| Sphingomyelins | 1 | 2002 | 114 | 0.230 |
Why?
|
| Caspase 3 | 5 | 2010 | 805 | 0.230 |
Why?
|
| Stem Cells | 4 | 2011 | 3593 | 0.230 |
Why?
|
| Carcinoma in Situ | 1 | 2008 | 821 | 0.230 |
Why?
|
| Fas Ligand Protein | 4 | 2010 | 229 | 0.220 |
Why?
|
| Fatty Acids, Omega-3 | 3 | 2018 | 1267 | 0.220 |
Why?
|
| Neovascularization, Pathologic | 5 | 2014 | 2715 | 0.220 |
Why?
|
| Drug Resistance, Neoplasm | 5 | 2018 | 5197 | 0.220 |
Why?
|
| Pyrroles | 3 | 2013 | 1182 | 0.220 |
Why?
|
| Tumor Cells, Cultured | 9 | 2020 | 6571 | 0.210 |
Why?
|
| Cytomegalovirus Infections | 2 | 2022 | 753 | 0.210 |
Why?
|
| Uterus | 5 | 2014 | 669 | 0.210 |
Why?
|
| Tissue Adhesions | 2 | 2012 | 227 | 0.210 |
Why?
|
| Phosphatidylinositol 3-Kinases | 5 | 2016 | 2936 | 0.210 |
Why?
|
| Papillomaviridae | 3 | 2022 | 1124 | 0.210 |
Why?
|
| Oncogene Proteins, Viral | 1 | 2022 | 384 | 0.200 |
Why?
|
| Tumor Suppressor Proteins | 4 | 2022 | 2895 | 0.200 |
Why?
|
| Steroids | 2 | 2002 | 880 | 0.190 |
Why?
|
| Transcription Factors | 7 | 2019 | 12005 | 0.190 |
Why?
|
| Myometrium | 2 | 2018 | 182 | 0.190 |
Why?
|
| Ceramides | 3 | 2008 | 193 | 0.190 |
Why?
|
| Adenocarcinoma | 6 | 2014 | 6338 | 0.180 |
Why?
|
| Alphapapillomavirus | 1 | 2022 | 220 | 0.180 |
Why?
|
| Enzyme Precursors | 1 | 1999 | 186 | 0.180 |
Why?
|
| Neoadjuvant Therapy | 1 | 2010 | 2561 | 0.180 |
Why?
|
| MAP Kinase Signaling System | 3 | 2003 | 1588 | 0.180 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2002 | 1321 | 0.180 |
Why?
|
| Mice, Inbred C57BL | 14 | 2019 | 22989 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 18 | 3 | 2007 | 252 | 0.170 |
Why?
|
| Receptors, Prostaglandin | 5 | 2005 | 61 | 0.170 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2013 | 4677 | 0.170 |
Why?
|
| Galectins | 1 | 2021 | 246 | 0.170 |
Why?
|
| Cell Count | 3 | 2014 | 1920 | 0.170 |
Why?
|
| Protein Kinase Inhibitors | 5 | 2017 | 5405 | 0.170 |
Why?
|
| Vascular Endothelial Growth Factor A | 4 | 2014 | 3490 | 0.170 |
Why?
|
| Receptors, Cell Surface | 3 | 2006 | 2913 | 0.170 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2019 | 3026 | 0.170 |
Why?
|
| Interferon-gamma | 4 | 2008 | 3245 | 0.160 |
Why?
|
| Reproduction | 2 | 2012 | 639 | 0.160 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 2018 | 315 | 0.160 |
Why?
|
| Gene Expression | 5 | 2015 | 8014 | 0.160 |
Why?
|
| Membrane Glycoproteins | 3 | 2003 | 3812 | 0.160 |
Why?
|
| Clone Cells | 1 | 2020 | 1767 | 0.160 |
Why?
|
| Endothelium, Vascular | 3 | 2008 | 4658 | 0.150 |
Why?
|
| Endometrial Hyperplasia | 1 | 2017 | 89 | 0.150 |
Why?
|
| Celiac Disease | 1 | 2004 | 749 | 0.150 |
Why?
|
| ras Proteins | 2 | 2013 | 1116 | 0.150 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2009 | 3876 | 0.150 |
Why?
|
| Feedback, Physiological | 1 | 2019 | 480 | 0.150 |
Why?
|
| RNA, Small Interfering | 5 | 2019 | 3645 | 0.150 |
Why?
|
| Tumor Burden | 4 | 2016 | 1906 | 0.150 |
Why?
|
| Cystadenoma, Serous | 1 | 2016 | 93 | 0.140 |
Why?
|
| Mice, Knockout | 9 | 2019 | 15274 | 0.140 |
Why?
|
| Blood Proteins | 1 | 2021 | 1144 | 0.140 |
Why?
|
| Drug Screening Assays, Antitumor | 3 | 2015 | 745 | 0.140 |
Why?
|
| Mediator Complex | 1 | 2015 | 108 | 0.140 |
Why?
|
| Mice, Nude | 7 | 2021 | 3859 | 0.140 |
Why?
|
| Papillomavirus Infections | 2 | 2022 | 1470 | 0.140 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2015 | 2668 | 0.140 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2014 | 1146 | 0.140 |
Why?
|
| Palliative Care | 1 | 2010 | 3261 | 0.140 |
Why?
|
| Immunoconjugates | 1 | 2022 | 831 | 0.140 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 3 | 2016 | 908 | 0.140 |
Why?
|
| GPI-Linked Proteins | 1 | 2016 | 453 | 0.140 |
Why?
|
| Serpins | 1 | 1997 | 269 | 0.140 |
Why?
|
| Cells, Cultured | 12 | 2019 | 20170 | 0.140 |
Why?
|
| Cleavage Stage, Ovum | 1 | 2014 | 49 | 0.140 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2011 | 8877 | 0.130 |
Why?
|
| Stromal Cells | 2 | 2011 | 1361 | 0.130 |
Why?
|
| Cyclic S-Oxides | 1 | 2014 | 21 | 0.130 |
Why?
|
| Cell Communication | 2 | 2020 | 1653 | 0.130 |
Why?
|
| Thiadiazoles | 1 | 2014 | 54 | 0.130 |
Why?
|
| Gene Expression Profiling | 6 | 2015 | 9556 | 0.130 |
Why?
|
| Pregnancy | 12 | 2018 | 26832 | 0.130 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2015 | 632 | 0.130 |
Why?
|
| Adrenomedullin | 1 | 2013 | 87 | 0.130 |
Why?
|
| Blotting, Western | 7 | 2014 | 5456 | 0.130 |
Why?
|
| Mice, Transgenic | 5 | 2019 | 9927 | 0.130 |
Why?
|
| DNA Methylation | 4 | 2015 | 4099 | 0.120 |
Why?
|
| Pituitary ACTH Hypersecretion | 1 | 2015 | 168 | 0.120 |
Why?
|
| Organ Specificity | 1 | 2019 | 2064 | 0.120 |
Why?
|
| S-Phase Kinase-Associated Proteins | 1 | 2013 | 96 | 0.120 |
Why?
|
| RNA, Neoplasm | 2 | 2014 | 780 | 0.120 |
Why?
|
| Extracellular Space | 1 | 2015 | 613 | 0.120 |
Why?
|
| Microsatellite Instability | 1 | 2017 | 664 | 0.120 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2018 | 444 | 0.120 |
Why?
|
| Hydroxamic Acids | 1 | 2016 | 507 | 0.120 |
Why?
|
| Polymorphism, Genetic | 1 | 2004 | 4293 | 0.120 |
Why?
|
| Chemokine CCL2 | 3 | 2008 | 658 | 0.120 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2014 | 139 | 0.120 |
Why?
|
| Menarche | 1 | 2015 | 485 | 0.120 |
Why?
|
| Mice, Inbred BALB C | 2 | 2017 | 6684 | 0.120 |
Why?
|
| Pituitary Gland | 1 | 2015 | 667 | 0.120 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2015 | 357 | 0.120 |
Why?
|
| Viral Proteins | 2 | 2019 | 1967 | 0.120 |
Why?
|
| Capillaries | 2 | 2008 | 781 | 0.120 |
Why?
|
| Genes, MDR | 1 | 2012 | 38 | 0.120 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2013 | 332 | 0.120 |
Why?
|
| Transplantation, Heterologous | 3 | 2011 | 2427 | 0.120 |
Why?
|
| Parity | 1 | 2015 | 888 | 0.110 |
Why?
|
| Veratrum Alkaloids | 1 | 2011 | 26 | 0.110 |
Why?
|
| Allosteric Site | 1 | 2012 | 111 | 0.110 |
Why?
|
| Neoplasm Staging | 6 | 2017 | 11126 | 0.110 |
Why?
|
| Meiosis | 1 | 2014 | 370 | 0.110 |
Why?
|
| Antigens, Ly | 1 | 2013 | 304 | 0.110 |
Why?
|
| Cytomegalovirus | 2 | 2022 | 681 | 0.110 |
Why?
|
| Genetic Fitness | 1 | 2012 | 112 | 0.110 |
Why?
|
| Azacitidine | 2 | 2010 | 297 | 0.110 |
Why?
|
| Sirolimus | 2 | 2017 | 1571 | 0.110 |
Why?
|
| Breast Neoplasms | 2 | 2017 | 19800 | 0.110 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2017 | 1158 | 0.110 |
Why?
|
| Blastocyst | 1 | 2014 | 431 | 0.110 |
Why?
|
| Nucleosomes | 1 | 1995 | 480 | 0.110 |
Why?
|
| Follicular Atresia | 2 | 2008 | 9 | 0.110 |
Why?
|
| Cell Lineage | 2 | 2019 | 2630 | 0.100 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2016 | 803 | 0.100 |
Why?
|
| Sheep | 4 | 1999 | 1484 | 0.100 |
Why?
|
| Gene Expression Regulation | 5 | 2015 | 12447 | 0.100 |
Why?
|
| Intestinal Neoplasms | 1 | 2013 | 300 | 0.100 |
Why?
|
| Theca Cells | 2 | 2008 | 15 | 0.100 |
Why?
|
| Interleukin-6 | 3 | 2013 | 3179 | 0.100 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2013 | 4065 | 0.100 |
Why?
|
| Receptor, Notch1 | 1 | 2014 | 524 | 0.100 |
Why?
|
| Progestins | 1 | 2012 | 283 | 0.100 |
Why?
|
| Promoter Regions, Genetic | 4 | 2019 | 6068 | 0.100 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2012 | 219 | 0.100 |
Why?
|
| beta Catenin | 3 | 2013 | 1053 | 0.100 |
Why?
|
| Blotting, Northern | 4 | 2007 | 1636 | 0.100 |
Why?
|
| Receptors, Leptin | 3 | 2006 | 344 | 0.100 |
Why?
|
| Enzyme Activation | 4 | 2010 | 3879 | 0.100 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2010 | 114 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 7 | 2014 | 4941 | 0.100 |
Why?
|
| Extracellular Matrix | 1 | 2018 | 1794 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 1997 | 1400 | 0.100 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2014 | 605 | 0.100 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2012 | 343 | 0.090 |
Why?
|
| Molecular Targeted Therapy | 3 | 2021 | 2878 | 0.090 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2016 | 1399 | 0.090 |
Why?
|
| DNA | 4 | 2002 | 7172 | 0.090 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2014 | 707 | 0.090 |
Why?
|
| Mucin-4 | 1 | 2009 | 38 | 0.090 |
Why?
|
| Cryoprotective Agents | 1 | 2009 | 92 | 0.090 |
Why?
|
| Neoplasm Metastasis | 1 | 2020 | 5112 | 0.090 |
Why?
|
| Fertilization in Vitro | 2 | 2014 | 1223 | 0.090 |
Why?
|
| Ganciclovir | 1 | 2009 | 261 | 0.090 |
Why?
|
| DNA Copy Number Variations | 2 | 2020 | 1894 | 0.090 |
Why?
|
| Mutation | 4 | 2014 | 29262 | 0.090 |
Why?
|
| Cell Separation | 2 | 2020 | 1835 | 0.090 |
Why?
|
| Luteal Cells | 3 | 2007 | 20 | 0.090 |
Why?
|
| Cisplatin | 2 | 2015 | 1651 | 0.090 |
Why?
|
| Homeostasis | 2 | 2019 | 3334 | 0.090 |
Why?
|
| Pancreas Transplantation | 1 | 2009 | 222 | 0.090 |
Why?
|
| Cell Cycle Proteins | 2 | 2019 | 3507 | 0.090 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2013 | 1095 | 0.090 |
Why?
|
| Scleroderma, Systemic | 1 | 2012 | 299 | 0.090 |
Why?
|
| Estrous Cycle | 1 | 2008 | 66 | 0.090 |
Why?
|
| Organ Culture Techniques | 2 | 2019 | 861 | 0.080 |
Why?
|
| Cell Survival | 5 | 2016 | 6156 | 0.080 |
Why?
|
| Immunomodulation | 1 | 2012 | 540 | 0.080 |
Why?
|
| Endothelial Cells | 3 | 2008 | 3417 | 0.080 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2007 | 143 | 0.080 |
Why?
|
| Cell Death | 2 | 2010 | 1738 | 0.080 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2010 | 2032 | 0.080 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2009 | 611 | 0.080 |
Why?
|
| Genes, ras | 1 | 2010 | 719 | 0.080 |
Why?
|
| Receptors, Interleukin-1 | 2 | 2008 | 264 | 0.080 |
Why?
|
| Oncogenes | 1 | 2013 | 1244 | 0.080 |
Why?
|
| Models, Biological | 4 | 2020 | 9907 | 0.080 |
Why?
|
| Immunity, Cellular | 1 | 2014 | 1693 | 0.080 |
Why?
|
| Postpartum Period | 1 | 2013 | 970 | 0.080 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2008 | 255 | 0.080 |
Why?
|
| Pregnancy, Animal | 1 | 2008 | 134 | 0.080 |
Why?
|
| Trans-Activators | 3 | 2010 | 3053 | 0.080 |
Why?
|
| Nervous System | 1 | 2010 | 563 | 0.080 |
Why?
|
| DNA Fragmentation | 3 | 2002 | 248 | 0.080 |
Why?
|
| Germ Cells | 2 | 2010 | 588 | 0.080 |
Why?
|
| DNA, Complementary | 3 | 2003 | 2100 | 0.080 |
Why?
|
| Embryo, Nonmammalian | 1 | 2010 | 957 | 0.080 |
Why?
|
| Homeodomain Proteins | 2 | 2014 | 2459 | 0.080 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2011 | 552 | 0.080 |
Why?
|
| Cell Differentiation | 4 | 2019 | 11718 | 0.080 |
Why?
|
| Ovum | 1 | 2007 | 199 | 0.080 |
Why?
|
| Receptors, Cytokine | 2 | 2004 | 253 | 0.080 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2019 | 3447 | 0.070 |
Why?
|
| Interferon Regulatory Factor-1 | 2 | 2008 | 71 | 0.070 |
Why?
|
| Glucocorticoids | 1 | 2015 | 2125 | 0.070 |
Why?
|
| Mesoderm | 1 | 2009 | 728 | 0.070 |
Why?
|
| Genes, MHC Class I | 1 | 2006 | 280 | 0.070 |
Why?
|
| Protein Isoforms | 2 | 2010 | 1712 | 0.070 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2008 | 616 | 0.070 |
Why?
|
| Genital Neoplasms, Female | 1 | 2010 | 510 | 0.070 |
Why?
|
| Zebrafish | 2 | 2022 | 3038 | 0.070 |
Why?
|
| Models, Animal | 1 | 2012 | 2221 | 0.070 |
Why?
|
| Colonic Neoplasms | 2 | 2009 | 2535 | 0.070 |
Why?
|
| Genetic Markers | 1 | 2012 | 2690 | 0.070 |
Why?
|
| Colon | 1 | 2013 | 1762 | 0.070 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2008 | 328 | 0.070 |
Why?
|
| Muscle, Smooth | 1 | 2009 | 945 | 0.070 |
Why?
|
| Phenotype | 5 | 2020 | 16306 | 0.070 |
Why?
|
| Dinucleotide Repeats | 1 | 2004 | 33 | 0.070 |
Why?
|
| Testicular Hormones | 1 | 2004 | 191 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 2 | 2021 | 9584 | 0.070 |
Why?
|
| Cyclin D1 | 1 | 2006 | 470 | 0.060 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2004 | 104 | 0.060 |
Why?
|
| Dietary Fats | 1 | 2012 | 2042 | 0.060 |
Why?
|
| Cloning, Molecular | 2 | 2004 | 4489 | 0.060 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2014 | 1805 | 0.060 |
Why?
|
| Genotype | 3 | 2015 | 12863 | 0.060 |
Why?
|
| Life Style | 1 | 2015 | 3636 | 0.060 |
Why?
|
| Prognosis | 8 | 2012 | 28919 | 0.060 |
Why?
|
| Neurogenesis |